Last CNY68.45 CNY
Change Today -0.19 / -0.28%
Volume 563.6K
300294 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 10:29 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

jiangxi boya bio-pharmaceu-a (300294) Snapshot

Open
CNY68.44
Previous Close
CNY68.64
Day High
CNY69.99
Day Low
CNY68.42
52 Week High
12/2/14 - CNY78.87
52 Week Low
04/28/14 - CNY39.98
Market Cap
5.2B
Average Volume 10 Days
895.0K
EPS TTM
CNY1.09
Shares Outstanding
75.8M
EX-Date
04/3/14
P/E TM
62.8x
Dividend
CNY0.50
Dividend Yield
0.73%
Current Stock Chart for JIANGXI BOYA BIO-PHARMACEU-A (300294)

Related News

No related news articles were found.

jiangxi boya bio-pharmaceu-a (300294) Related Businessweek News

No Related Businessweek News Found

jiangxi boya bio-pharmaceu-a (300294) Details

Jiangxi Boya Bio-Pharmaceutical Company Limited researches, develops, produces, and distributes blood products primarily in China. The company’s products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human immune globulin, hydrophobia human immune globulin, human fibrinogen, and others. Its albumin products are used in the therapy of tumor, liver disease, and diabetes mellitus; and immune globulin products are used in the therapy of immunity diseases and infection diseases. The company was founded in 1993 and is based in Fuzhou, China.

Founded in 1993

jiangxi boya bio-pharmaceu-a (300294) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jiangxi boya bio-pharmaceu-a (300294) Key Developments

Jiangxi Boya Bio-Pharmaceutical Co., Ltd, Special/Extraordinary Shareholders Meeting, Jan 14, 2015

Jiangxi Boya Bio-Pharmaceutical Co., Ltd, Special/Extraordinary Shareholders Meeting, Jan 14, 2015., at 14:00 China Standard Time. Agenda: To consider the connected transaction regarding the transfer of 32% equity stake in a company; and to approve by-election of supervisors.

Jiangxi Boya Bio-Pharmaceutical Co., Ltd to Report Q3, 2014 Results on Oct 25, 2014

Jiangxi Boya Bio-Pharmaceutical Co., Ltd announced that they will report Q3, 2014 results on Oct 25, 2014

Jiangxi Boya Bio-Pharmaceutical Co., Ltd Approves Amendment to the Articles of Association

Jiangxi Boya Bio-Pharmaceutical Co. Ltd. approved amendments to the company's articles of association, at its extraordinary general meeting of 2014 held on August 12, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300294:CH CNY68.45 CNY -0.19

300294 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Beijing Tiantan Biological Products Corp Ltd CNY30.20 CNY 0.00
China Biologic Products Inc $69.23 USD +0.93
Hualan Biological Engineering Inc CNY36.50 CNY -0.85
Shanghai RAAS Blood Products Co Ltd CNY47.48 CNY +0.84
View Industry Companies
 

Industry Analysis

300294

Industry Average

Valuation 300294 Industry Range
Price/Earnings 52.9x
Price/Sales 14.0x
Price/Book 6.2x
Price/Cash Flow 53.2x
TEV/Sales 13.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANGXI BOYA BIO-PHARMACEU-A, please visit www.china-boya.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.